2015;8:1413 21. S7.3-34. Choudhary N, Tompkins C, Polonsky B, et al. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: findings from the North American ARVC Registry. J Cardiovasc Electrophysiol. 2016;27:555 62. S7.3-35. Kamath GS, Zareba W, Delaney J, et al. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopa- thy/dysplasia. Heart Rhythm. 2011;8:256 62. S7.3-36. Saguner AM, Medeiros-Domingo A, Schwyzer MA, et al. Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2013;111:250 7. S7.3-37. Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhyth- mogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol. 2008;52:2175 87. S7.3-38. Te Riele AS, James CA, Philips B, et al. Mutation-positive arrhyth- mogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013;24: 1311 20. S7.3-39. Rastegar N, Zimmerman SL, Te Riele AS, et al. Spectrum of biven- tricular involvement on cmr among carriers of arvd/c-associated mutations. JACC Cardiovasc Imag. 2015;8:863 4. S7.3-40. Sen-Chowdhry S, Syrris P, Ward D, et al. Clinical and genetic charac- terization of families with arrhythmogenic right ventricular dyspla- sia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115:1710 20. S7.3-41. Dalal D, Nasir K, Bomma C, et al. Arrhythmogenic right ventricu- lar dysplasia: a United States experience. Circulation. 2005;112: 3823 32. S7.3-42. Brun F, Groeneweg JA, Gear K, et al. Risk stratification in arrhythmic right ventricular cardiomyopathy without implantable cardioverter- defibrillators. JACC Clin Electrophysiol. 2016;2:558 64. S7.3-43. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084 91. S7.3-44. van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study. 